412.0K XNAS Volume
XNAS 24 Mar, 2025 1:53 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 165,075 (0%) | 0% | 0 | common stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 454,153 | 4,111,417 (5%) | 0% | 0 | Common stock, par value $0.001 | |
| Michael S. Weiss | Director, Executive Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 454,153 | 1,801,138 (2%) | 0% | 0 | common stock, par value $0.001 | |
| Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 88,425 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Jimmie Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 119,382 (0%) | 0% | 0 | common stock, par value $0.001 | |
| Lucy Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 61,273 (0%) | 0% | 0 | common stock, par value $0.001 | |
| Dov Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 102,783 (0%) | 0% | 0 | common stock, par value $0.001 | |
| Jin David | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 1,000,000 | 1,240,893 (1%) | 1% | 0 | Common Stock, par value $0.001 | |
| David Jin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.23 per share. | 01 Oct 2024 | 2,625 | 240,893 (0%) | 0% | 1.2 | 3,224 | Common Stock, par value $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 23 Sep 2024 | 763,359 | 3,657,264 (5%) | 1% | 1.8 | 1,404,581 | Common stock, par value $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Sep 2024 | 763,359 | 763,359 | - | - | Warrants to Purchase Common Stock | |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.48 per share. | 11 Jul 2024 | 5,000 | 127,500 | - | 7.5 | 37,418 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| David Jin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.50 per share. | 10 Jul 2024 | 500 | 500 | - | 7.5 | 3,750 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.39 per share. | 09 Jul 2024 | 5,000 | 122,500 | - | 7.4 | 36,971 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.35 per share. | 08 Jul 2024 | 5,000 | 117,500 | - | 7.4 | 36,765 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 28 Jun 2024 | 20,000 | 2,893,905 (4%) | 0% | 1.6 | 32,724 | COMMON STOCK, PAR VALUE $0.001 |
| Dov Klein | Director | Sale of securities on an exchange or to another person at price $ 1.89 per share. | 20 May 2024 | 10,000 | 53,400 (0%) | 0% | 1.9 | 18,900 | COMMON STOCK, PAR VALUE $0.001 |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 16 May 2024 | 10,000 | 2,873,905 (4%) | 0% | 1.8 | 17,589 | COMMON STOCK, PAR VALUE $0.001 |
| David Jin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 01 Apr 2024 | 2,352 | 238,268 (0%) | 0% | 1.7 | 3,998 | COMMON STOCK, PAR VALUE $0.001 |
| Rosenwald Lindsay A. | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 05 Jan 2024 | 50,000 | 2,863,905 (4%) | 0% | 2.4 | 118,770 | COMMON STOCK, PAR VALUE $0.001 |
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,666 | 115,692 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Eric Rowinsky K. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,666 | 68,797 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Rosenwald A. Lindsay | Director, President, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 216,465 | 2,813,905 (3%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,333 | 39,042 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Michael Weiss S. | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 216,465 | 1,346,985 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Klein Dov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,666 | 63,400 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lu Lucy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,333 | 11,890 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Jin David | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2023 | 140,000 | 235,916 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.75 per share. | 17 Aug 2023 | 10,000 | 102,500 | - | 11.8 | 117,500 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.34 per share. | 17 Aug 2023 | 10,000 | 112,500 | - | 9.3 | 93,400 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Eric K. Rowinsky | Director | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 11,976 | 931,976 (1%) | 0% | 0.8 | 10,000 | COMMON STOCK, PAR VALUE $0.001 |
| J. Jay Lobell | Director | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 299,401 | 1,635,401 (2%) | 0% | 0.8 | 250,000 | COMMON STOCK, PAR VALUE $0.001 |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 2,395,209 | 15,349,091 (21%) | 3% | 0.8 | 2,000,000 | COMMON STOCK, PAR VALUE $0.001 |
| Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 10 Feb 2023 | 1,197,604 | 14,752,034 (20%) | 1% | 0.8 | 999,999 | COMMON STOCK, PAR VALUE $0.001 |
| Lucy Lu | Director | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 11,976 | 133,379 (0%) | 0% | 0.8 | 10,000 | COMMON STOCK, PAR VALUE $0.001 |
| David Jin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 35,928 | 1,438,757 (2%) | 0% | 0.8 | 30,000 | COMMON STOCK, PAR VALUE $0.001 |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 100,000 | 920,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 100,000 | 1,336,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,219,294 | 12,953,882 (18%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, President, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Jan 2023 | 4,264 | 11,734,588 (16%) | 0% | 0.7 | 3,113 | COMMON STOCK, PAR VALUE $0.001 |
| Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,219,294 | 13,554,430 (19%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 50,000 | 535,636 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Jimmie Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 100,000 | 950,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lucy Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 50,000 | 121,403 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Dov Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 100,000 | 851,015 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lucy Lu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 30,000 | 71,403 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 01 Dec 2022 | 100,000 | 11,730,324 (16%) | 0% | 0.7 | 67,960 | COMMON STOCK, PAR VALUE $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 30 Nov 2022 | 5,000 | 11,630,324 (16%) | 0% | 0.6 | 2,800 | COMMON STOCK, PAR VALUE $0.001 |
| David Jin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 30 Nov 2022 | 5,000 | 1,402,829 (1%) | 0% | 0.6 | 2,800 | COMMON STOCK, PAR VALUE $0.001 |
| David Jin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 1,350,000 | 1,397,829 (1%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 21 Oct 2022 | 100,000 | 11,625,324 (16%) | 0% | 0.7 | 69,500 | COMMON STOCK, PAR VALUE $0.001 |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 100,000 | 820,000 (1%) | 0% | 0 | Common Stock, par value $0.001 | |
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 100,000 | 1,236,000 (1%) | 0% | 0 | Common Stock, par value $0.001 | |
| Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 1,102,986 | 12,335,136 (17%) | 1% | 0 | Common Stock | |
| Jimmie Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 100,000 | 850,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Robyn M Hunter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 22 Sep 2020 | 28,450 | 192,169 (0%) | 0% | 4.4 | 124,611 | Common Stock, par value $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 26 Aug 2020 | 52,500 | 92,500 | - | 18 | 945,000 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Malcolm Hoenlein | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 26 Aug 2020 | 16,667 | 16,667 | - | 18 | 300,006 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 100,000 | 650,000 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 100,000 | 1,036,000 (1%) | 0% | 0 | Common Stock, par value $0.001 | |
| Michael S. Weiss | Director, EXECUTIVE VICE CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 801,536 | 10,201,811 (14%) | 1% | 0 | Common Stock | |
| Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 50,000 | 385,000 (0%) | 0% | 0 | Common Stock | |
| Jimmie Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 100,000 | 650,000 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Dov Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2020 | 100,000 | 555,000 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.26 per share. | 18 Jul 2019 | 396,825 | 8,569,722 (12%) | 0% | 1.3 | 500,000 | COMMON STOCK, PAR VALUE $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2019 | 801,536 | 9,373,848 (13%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 03 Jun 2019 | 1,467 | 8,571,189 (12%) | 0% | 1.1 | 1,614 | COMMON STOCK, PAR VALUE $0.001 |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 03 Jun 2019 | 1,123 | 8,572,312 (12%) | 0% | 2.1 | 2,313 | COMMON STOCK, PAR VALUE $0.001 |
| Robyn M Hunter | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 03 Jun 2019 | 2,297 | 220,619 (0%) | 0% | 1.1 | 2,527 | Common Stock, par value $0.001 |
| Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2019 | 100,000 | 550,000 (0%) | 0% | 0 | Common Stock | |
| J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2019 | 100,000 | 936,000 (1%) | 0% | 0 | Common Stock | |
| Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2019 | 50,000 | 335,000 (0%) | 0% | 0 | Common Stock | |
| Jimmie Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2019 | 100,000 | 550,000 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2018 | 200,000 | 200,000 | - | - | Options to purchase Common Stock | |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2018 | 400,000 | 655,170 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Robyn M Hunter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 23 Nov 2018 | 20,370 | 239,759 (0%) | 0% | 1.3 | 26,277 | Common Stock |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 100,000 | 450,000 (0%) | 0% | 0 | Common Stock | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 100,000 | 786,000 (1%) | 0% | 0 | Common Stock | |
| Lindsay A. Rosenwald | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 586,428 | 7,358,706 (14%) | 1% | 0 | Common Stock | |
| Lindsay A. Rosenwald | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 164,473 | 7,523,179 (13%) | 0% | 0 | Common Stock | |
| Lindsay A. Rosenwald | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 1,514 | 7,524,693 (13%) | 0% | 0 | Common Stock | |
| Lindsay A. Rosenwald | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 648,204 | 8,172,897 (14%) | 1% | 0 | Common Stock | |
| Michael S. Weiss | Director, EXECUTIVE VICE CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 648,204 | 9,400,275 (16%) | 1% | 0 | Common Stock | |
| Michael S. Weiss | Director, EXECUTIVE VICE CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 164,473 | 8,752,071 (16%) | 0% | 0 | Common Stock | |
| Michael S. Weiss | Director, EXECUTIVE VICE CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 586,428 | 8,587,598 (16%) | 1% | 0 | Common Stock | |
| Malcolm Hoenlein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 50,000 | 285,000 (0%) | 0% | 0 | Common Stock | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 100,000 | 450,000 (0%) | 0% | 0 | Common Stock | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 100,000 | 455,000 (0%) | 0% | 0 | Common Stock | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2018 | 100,000 | 355,000 (0%) | 0% | 0 | Common Stock | |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Sale of securities on an exchange or to another person at price $ 3.55 per share. | 14 Dec 2017 | 12,000 | 352,495 (0%) | 0% | 3.6 | 42,600 | COMMON STOCK, PAR VALUE $0.001 |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 29 Nov 2017 | 19,000 | 364,495 (0%) | 0% | 3.6 | 67,830 | COMMON STOCK, PAR VALUE $0.001 |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Sale of securities on an exchange or to another person at price $ 3.59 per share. | 29 Nov 2017 | 25,593 | 383,495 (0%) | 0% | 3.6 | 91,879 | COMMON STOCK, PAR VALUE $0.001 |
| George C. Avgerinos | SVP, BIOLOGICS OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2017 | 150,000 | 409,088 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Lindsay A. Rosenwald | Director, PRESIDENT, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 06 Nov 2017 | 40,000 | 40,000 (0%) | 0% | 25 | 1,000,000 | SERIES A CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK |
| Dov Klein | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2017 | 13,333 | 201,668 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2017 | 13,333 | 53,332 | - | - | Deferred Restricted Stock Units | |
| Malcolm Hoenlein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2017 | 16,666 | 49,998 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2017 | 16,666 | 49,998 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2017 | 16,666 | 49,998 | - | - | Deferred Restricted Stock Units | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 100,000 | 350,000 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 100,000 | 686,000 (1%) | 0% | 0 | Common Stock, par value $0.001 | |
| Michael S. Weiss | Director, Exec. VC - Strategic Dev., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 552,698 | 8,001,170 (16%) | 1% | 0 | Common Stock, par value $0.001 | |
| Malcolm Hoenlein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 16,666 | 33,332 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 16,666 | 33,332 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 16,666 | 33,332 | - | - | Deferred Restricted Stock Units | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 100,000 | 241,667 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2017 | 26,666 | 39,999 | - | - | Deferred Restricted Stock Units | |
| Dov Klein | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jan 2017 | 26,666 | 215,001 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2016 | 731 | 5,304,470 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2016 | 552,698 | 5,857,168 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 33,912 | 259,088 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 15,000 | 293,000 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 150,000 | 308,000 | - | - | Common Stock, par value $0.001 | |
| Dov Klein | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2016 | 13,333 | 141,667 | - | - | Common Stock, par value $0.001 | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2016 | 13,333 | 13,333 | - | - | Deferred Restricted Stock Units | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Jun 2016 | 613 | 5,303,739 | - | - | Common Stock, par value $0.001 | |
| Malcolm Hoenlein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2016 | 16,666 | 16,666 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2016 | 16,666 | 16,666 | - | - | Deferred Restricted Stock Units | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2016 | 16,666 | 16,666 | - | - | Deferred Restricted Stock Units | |
| Michael S. Weiss | Director, Exec. VC - Strategic Dev., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2016 | 510,434 | 7,448,472 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2016 | 510,434 | 5,303,126 | - | - | Common Stock, par value $0.001 | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2016 | 100,000 | 250,000 | - | - | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2016 | 100,000 | 586,000 | - | - | Common Stock, par value $0.001 | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2016 | 100,000 | 155,000 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2015 | 586 | 4,792,692 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2015 | 22,737 | 189,299 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2015 | 31,299 | 158,000 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Sep 2015 | 11,704 | 226,136 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Sep 2015 | 14,100 | 212,036 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Sep 2015 | 2,136 | 237,840 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Sep 2015 | 24,900 | 258,176 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Sep 2015 | 18,200 | 239,976 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2015 | 158 | 283,076 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2015 | 3,500 | 283,234 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2015 | 10,000 | 286,734 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2015 | 11,266 | 296,734 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2015 | 300,000 | 308,000 | - | - | Common Stock, par value $0.001 | |
| George C. Avgerinos | SVP, Biologics Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2015 | 200,000 | 0 | - | - | Options to purchase Common Stock | |
| Dov Klein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2015 | 50,000 | 55,000 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Jun 2015 | 785 | 4,792,106 | - | - | Common Stock, par value $0.001 | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2015 | 50,000 | 100,000 | - | - | Common Stock, par value $0.001 | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2015 | 50,000 | 150,000 | - | - | Common Stock, par value $0.001 per share | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2015 | 50,000 | 436,000 | - | - | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2015 | 50,000 | 486,000 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2014 | 974 | 4,791,321 | - | - | Common Stock, par value $0.001 | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2014 | 5,000 | 35,631 | - | - | Common Stock, par value $0.001 | |
| Michael S. Weiss | Director, Exec. VC - Strategic Dev., Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Nov 2014 | 1,000,000 | 6,938,038 | - | - | Common Stock, par value $0.001 | |
| Malcolm Hoenlein | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Nov 2014 | 25,000 | 55,000 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Nov 2014 | 150,000 | 4,790,347 | - | - | Common Stock, par value $0.001 | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Jun 2014 | 5,000 | 30,631 | - | - | Common Stock, par value $0.001 | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2014 | 47,566 | 0 | - | - | Options to purchase Common Stock | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2014 | 47,566 | 47,566 | - | - | Common Stock | |
| Kevin Horgan | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Apr 2014 | 47,566 | 0 | - | - | Common Stock | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2014 | 19,000 | 19,000 | - | - | Common Stock | |
| Kevin Horgan | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Apr 2014 | 19,000 | 0 | - | - | Common Stock | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2014 | 19,000 | 47,566 | - | - | Options to purchase Common Stock | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2014 | 101 | 66,566 | - | - | Options to purchase Common Stock | |
| Kevin Horgan | Other | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2014 | 101 | 101 | - | - | Common Stock | |
| Kevin Horgan | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Apr 2014 | 101 | 0 | - | - | Common Stock | |
| David J. Barrett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 50,000 | 50,000 | - | - | Common Stock, par value $0.001 | |
| Michael S. Weiss | Director, Exec. VC - Strategic Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 3,958,692 | 5,938,038 | - | - | Common Stock, par value $0.001 | |
| Malcolm Hoenlein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 30,000 | 30,000 | - | - | Common Stock, par value $0.001 per share | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 50,000 | 50,000 | - | - | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 50,000 | 386,000 | - | - | Common Stock, par value $0.001 | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2014 | 50,000 | 50,000 | - | - | Common Stock, par value $0.001 | |
| David J. Barrett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| Michael S. Weiss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| Michael S. Weiss | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 1,979,346 | 1,979,346 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 1,979,346 | 4,638,347 | - | - | Common Stock, par value $0.001 | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2013 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Dec 2013 | 1,107 | 25,631 | - | - | Common Stock, par value $0.001 | |
| Kevin Horgan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2013 | 200,000 | 200,000 | - | - | Options to purchase Common Stock | |
| J. Jay Lobell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Aug 2013 | 5,000 | 336,000 | - | - | Common Stock | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Aug 2013 | 5,000 | 24,524 | - | - | Common Stock, par value $0.001 | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Jul 2013 | 4,545 | 19,524 | - | - | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Jun 2013 | 10,000 | 331,000 | - | - | Common Stock | |
| Harlan F. Weisman | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Jun 2013 | 10,000 | 30,000 | - | - | Common Stock | |
| George Avgerinos | SVP, Biologics Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2013 | 200,000 | 200,000 | - | - | Options to purchase Common Stock | |
| Dale Ritter | SVP & Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2013 | 1,503 | 11,503 | - | - | Common Stock, par value $0.001 | |
| Noah D. Beerman | Executive VP and COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2013 | 5,000 | 15,000 | - | - | Common Stock, par value $0.001 | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 May 2013 | 4,979 | 14,979 | - | - | Common Stock, par value $0.001 | |
| Bobby W. Sandage | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2013 | 3,000 | 22,311 | - | - | Common Stock, par value $0.001 | |
| David J. Barrett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2013 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Michael W. Rogers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2013 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2013 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2013 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Harlan F. Weisman | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Jan 2013 | 20,000 | 20,000 | - | - | Common Stock | |
| Harlan F. Weisman | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2013 | 1,686,590 | 1,686,590 | - | - | Options to purchase Common Stock | |
| Bobby W. Sandage | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Nov 2012 | 3,811 | 25,311 | - | - | Common Stock, par value $0.001 | |
| Glenn L. Cooper | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Nov 2012 | 3,811 | 43,811 | - | - | Common Stock, par value $0.001 | |
| Bobby W. Sandage | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 10,000 | 21,500 | - | - | Common Stock, par value $0.001 | |
| Dale Ritter | SVP & Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 5,000 | 10,000 | - | - | Common Stock, par value $0.001 | |
| Glenn L. Cooper | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 10,000 | 40,000 | - | - | Common Stock, par value $0.001 | |
| Noah D. Beerman | EVP & COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 5,000 | 10,000 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 200,000 | 2,659,001 | - | - | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 25,000 | 321,000 | - | - | Common Stock, par value $0.001 | |
| Lucy Lu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 10,000 | 10,000 | - | - | Common Stock, par value $0.001 | |
| Karin M. Hehenberger | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2012 | 20,000 | 20,925 | - | - | Common Stock, par value $0.001 | |
| Dale Ritter | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2012 | 30,000 | 30,000 | - | - | Options to purchase Common Stock | |
| David J. Barrett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Glenn L. Cooper | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 45,000 | 45,000 | - | - | Options to purchase Common Stock | |
| Michael W. Rogers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Eric K. Rowinsky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Jimmie Harvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2012 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2012 | 2,000 | 2,461,001 | - | - | Common Stock, par value $.001 per share | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Jan 2012 | 2,000 | 2,423,632 | - | - | Common Stock, par value $.001 per share | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Jan 2012 | 2,000 | 2,421,632 | - | - | Common Stock, par value $.001 per share | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Jan 2012 | 2,000 | 2,419,632 | - | - | Common Stock, par value $.001 per share | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Jan 2012 | 2,000 | 2,417,632 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jan 2012 | 2,000 | 2,415,632 | - | - | Common Stock, par value $0.001 | |
| Noah D. Beerman | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Jan 2012 | 5,000 | 5,000 | - | - | Common Stock, par value $0.001 | |
| Bobby W. Sandage | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2012 | 500 | 500 | - | - | Common Stock, par value $0.001 | |
| Bobby W. Sandage | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2012 | 1,000 | 1,500 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2012 | 2,000 | 2,411,632 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2012 | 2,000 | 2,413,632 | - | - | Common Stock, par value $0.001 | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Dec 2011 | 2,000 | 2,409,632 | - | 0 | Common Stock, par value $0.001 | |
| J. Jay Lobell | None | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 3,337 | 0 | - | - | Warrant to purchase Common Stock | |
| J. Jay Lobell | None | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 17,878 | 0 | - | - | Options to purchase Common Stock | |
| J. Jay Lobell | None | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 5,960 | 0 | - | - | Warrant to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 3,337 | 0 | - | - | Warrant to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 17,878 | 0 | - | - | Warrant to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Nov 2011 | 5,960 | 0 | - | - | Warrant to purchase Common Stock | |
| J. Jay Lobell | None | Other type of transaction at price $ 0.00 per share. | 25 Oct 2011 | 3,399 | 3,399 | - | - | Warrants to purchase Common Stock | |
| J. Jay Lobell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2011 | 15,000 | 15,000 | - | - | Options to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2011 | 850 | 850 | - | - | Warrants to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2011 | 6,798 | 6,798 | - | - | Warrants to purchase Common Stock | |
| Lindsay A. Rosenwald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2011 | 3,399 | 3,399 | - | - | Warrants to purchase Common Stock |